PROTAGENIC

LIVE

Serial Number

97160442

Owner

Protagenic Therapeutics, Inc.

Attorney

Erik M. Pelton

First Use Date

Aug 29, 2023

Filing Date

Dec 7, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

PROTAGENIC Trademark

Serial Number: 97160442 • Registration: 7589137

PROTAGENIC is a trademark filed by Protagenic Therapeutics, Inc. on December 7, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Protagenic Therapeutics, Inc. (3 trademarks)

149 Fifth Avenue, Suite 500
New York, NY 10010

Entity Type: 03

Legal Representation

Attorney of Record

Erik M. Pelton

7,321 trademarks filed View all →

Trademark Details

Filing Date

December 7, 2021

Registration Date

December 3, 2024

First Use Anywhere

August 29, 2023

First Use in Commerce

August 29, 2023

Published for Opposition

March 21, 2023

Goods & Services

Pharmaceutical products for the treatment of stress, PTSD, depression, anxiety, addiction, addiction withdrawal symptoms, brain functions, neuropsychiatric disorders, and neurodegenerative diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 3, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Dec 3, 2024 R.PR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Feb 16, 2024 ERRR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 13, 2024 EXRA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 13, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 12, 2024 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Feb 10, 2024 SUPC

SOU EXTENSION 1 GRANTED

Feb 10, 2024 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 10, 2024 AITU

USE AMENDMENT FILED

Jan 22, 2024 IUAF

NOTICE OF REVIVAL - E-MAILED

Jan 22, 2024 NREV

TEAS STATEMENT OF USE RECEIVED

Jan 22, 2024 EISU

SOU EXTENSION RECEIVED WITH TEAS PETITION

Jan 22, 2024 TPEX

NOTICE OF REVIVAL - E-MAILED

Jan 22, 2024 NREV

PETITION TO REVIVE-GRANTED

Jan 22, 2024 PETG

TEAS PETITION TO REVIVE RECEIVED

Jan 22, 2024 PROA

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 18, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Dec 18, 2023 ABN6

SOU EXTENSION 1 FILED

Nov 16, 2023 EXT1

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 16, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 21, 2023 NPUB

PUBLISHED FOR OPPOSITION

Mar 21, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 1, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 14, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 6, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 5, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 5, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 20, 2022 GNRN

NON-FINAL ACTION E-MAILED

Sep 20, 2022 GNRT

NON-FINAL ACTION WRITTEN

Sep 20, 2022 CNRT

ASSIGNED TO EXAMINER

Sep 14, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 13, 2021 NWOS

NEW APPLICATION ENTERED

Dec 10, 2021 NWAP

Related Trademarks

More from this Owner

PIONEERING NEURONAL HEALTH

PROTAGENIC THERAPEUTICS

More in Same Class

ANGROW

SARXION BIOLOGICS

ASTEROID THERAPEUTICS

HAPYX

A ADELA